TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma.

Amod A Sarnaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.